Skip to main content
logo
Mersana Therapeutics, Inc. (MRSN)
Jan 6, 2026 - MRSN was delisted (reason: acquired by DAWN)
29.08
+0.04 (0.14%)
Inactive · Last trade price on Jan 5, 2026

Mersana Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
1451772805854471,823
Market Cap Growth
-42.03%-36.85%-52.15%30.71%-75.46%564.32%
Enterprise Value
9153733322761,569
Last Close Price
29.0835.7558.00146.50155.50665.25

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
4.364.367.5922.0010402.132201.35
PB Ratio
--18.587.586.353.677.99
P/TBV Ratio
--7.586.353.677.99

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
EV/Sales Ratio
2.751.311.9912.486408.321894.81

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
-0.04-3.010.920.400.320.07
Asset Turnover
0.290.220.130.1000.00
Quick Ratio
1.312.153.293.403.748.50
Current Ratio
1.392.193.363.493.988.62
Return on Equity (ROE)
--505.14%-266.24%-191.03%-97.22%-57.47%
Return on Assets (ROA)
-36.27%-24.73%-38.13%-47.13%-44.02%-28.91%
Return on Invested Capital (ROIC)
--101.99%-107.10%-88.01%-52.05%-33.24%
Return on Capital Employed (ROCE)
-347.00%-89.20%-105.30%-83.90%-106.50%-36.20%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
-48.20%-39.17%-61.37%-34.93%-38.02%-4.83%
FCF Yield
-51.15%-46.69%-61.14%-8.82%-31.44%-4.12%
Buyback Yield / Dilution
-2.10%-5.54%-23.98%-32.69%-14.79%-41.37%
SEC Filings: 10-K · 10-Q